Since overexpression of miR-26b suppressed the proliferation of MDA-MB-231 breast cancer cells, and given that PTGS2 is a direct target of miR-26b, we hypothesized that the inhibitory effect of miR-26b on breast cancer cell viability might be achieved via targeting PTGS2. The gene discussed is PTGS2; the disease is breast cancer.